Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Johnson & Johnson shareholders reject proposal for 'say on pay' of executives by narrow vote
Yahoo/AP
Thursday, April 22, 2010 - 4:16pm
tags:
JNJ, say-on-pay, pharmaceutical executives, executive pay
Bristol-Myers' Post-Plavix Worldview Has Some Big Blind Spots
BNET Pharma
Thursday, April 22, 2010 - 4:14pm
tags:
Bristol-Myers Squibb, Plavix, Sanofi
Doctors sign on to tough conflicts-of-interest rules
Fierce Pharma
Thursday, April 22, 2010 - 4:13pm
tags:
physicians, physician payments
Pfizer for the Long Haul
Seeking Alpha
Thursday, April 22, 2010 - 11:11am
tags:
Pfizer, patents, pipelines
Acura Pharma: FDA Panel Live Blog
TheStreet.com
Thursday, April 22, 2010 - 11:06am
tags:
Acura Pharmaceuticals, FDA, Acurox
Endo Pharmaceuticals Has Some Upside
Seeking Alpha
Thursday, April 22, 2010 - 10:56am
tags:
Watson Pharmaceuticals, Teva Pharmaceuticals, Merck, Endo, pain management, Opana, lidoderm, percocet
[video] Merck Breaks Lower
TheStreet.com
Thursday, April 22, 2010 - 10:47am
tags:
Merck
Theravance's Loss Widens
Yahoo/Zacks.com
Thursday, April 22, 2010 - 10:46am
tags:
Theravance, earnings, GSK, Astellas
Vical announces positive vaccine study data
Yahoo/AP
Thursday, April 22, 2010 - 10:29am
tags:
Vical, clinical trials, vaccines, stem cells, TransVax
FDA Proposes New Disclosure Rules For Panels
Pharmalot
Thursday, April 22, 2010 - 10:27am
tags:
FDA, advisory panels
Merck Loses Patent Ruling Over Zetia
Pharmalot
Thursday, April 22, 2010 - 10:23am
tags:
Merck, patents, Zetia, Glenmark
Codexis Sells IPO at Low End as Alimera Cuts Price
Businessweek
Thursday, April 22, 2010 - 10:22am
tags:
IPOs, Codexis, Alimera, biotech
Health-Care Overhaul and Drugmaker Outlook: Amgen
WSJ Online
Thursday, April 22, 2010 - 10:18am
tags:
healthcare reform, Amgen, earnings, Eli Lilly, Gilead Sciences, JNJ, Abbott Laboratories
Will AspenBio Pharma Follow in Dendreon and Human Genome Sciences' Footsteps?
Seeking Alpha
Thursday, April 22, 2010 - 7:30am
tags:
AspenBio, Novartis, Human Genome Sciences, Dendreon
Sanofi Aventis: Deeply Committed to China
Seeking Alpha
Thursday, April 22, 2010 - 7:12am
tags:
China, Sanofi
Merck’s Vytorin, Zetia Co-Pay Doubled by UnitedHealth
Bloomberg
Thursday, April 22, 2010 - 6:45am
tags:
Merck, Vytorin, Zetia, United Health
Spectrum Pharmaceuticals: Looking Ahead at Continued Growth
Seeking Alpha
Thursday, April 22, 2010 - 6:44am
tags:
Spectrum Pharmaceuticals, Zevalin
Novartis kidney-transplant drug is cleared by FDA
Marketwatch
Thursday, April 22, 2010 - 6:43am
tags:
Novartis, FDA, kidney transplant, Zortress
Amgen reports higher profit, increased sales
Marketwatch
Thursday, April 22, 2010 - 6:42am
tags:
Amgen, earnings
Dendreon touts Provenge test results
Bizjournals.com
Wednesday, April 21, 2010 - 3:52pm
tags:
Provenge, prostate cancer, Dendreon

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.